Lv61
1860 积分 2024-06-18 加入
Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signaling
1小时前
已完结
Wild-type RAS signaling is an essential therapeutic target in RAS -mutated cancers
2小时前
已完结
Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors
5小时前
已完结
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
6天前
已完结
Direct Ser797 Interacted Pteridine-7(8H)-one Derivatives as Highly Selective and Orally Available EGFRL858R/T790M/C797S Inhibitors
10天前
已完结
Extrachromosomal DNA — Amping Up Cancer
11天前
已完结
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defects
11天前
已完结
NSD3: Advances in cancer therapeutic potential and inhibitors research
12天前
已完结
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
14天前
已完结
Zanzalintinib (XL092): a next-generation tyrosine kinase inhibitor—comprehensive review of early safety & efficacy data
14天前
已完结
皖公网安备34019202002308
